共 21 条
[1]
Saydah S.H., Eberhardt M.S., Loria C.M., Et al., Age and the burden of death attributable to diabetes in the United states, Am J Epidemiol, 156, pp. 714-719, (2002)
[2]
Franco O.H., Steyerberg E.W., Hu F.B., Et al., Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease, Arch Intern Med, 167, pp. 1145-1151, (2007)
[3]
Almdal T., Scharling H., Jensen J.S., Et al., The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up, Arch Intern Med, 164, pp. 1422-1442, (2004)
[4]
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), UK Prospective Diabetes Study (UKPDS) Group. Lancet., 352, pp. 837-853, (1998)
[5]
Holman R.R., Paul S.K., Bethel M.A., Et al., 10-year follow-up of intensive glucose control in type 2 diabetes, N Engl J Med, 359, pp. 1577-1589, (2008)
[6]
Gaede P., Oellgaard J., Carstensen B., Et al., Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial, Diabetologia, 59, (2016)
[7]
Gerstein H.C., Miller M.E., Byington R.P., Et al., Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, pp. 2545-2559, (2008)
[8]
Patel A., MacMahon S., Chalmers J., Et al., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med, 358, pp. 2560-2572, (2008)
[9]
Duckworth W., Abraira C., Moritz T., Et al., Glucose control and vascular complications in veterans with type 2 diabetes, N Engl J Med, 360, pp. 129-139, (2009)
[10]
European Medicines Agencies (EMA). Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus.